Lakeridge Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
642
+14
+2% +$4.79K 0.09% 167
2026
Q1
$221K Buy
+628
New +$224K 0.1% 156
2024
Q4
Sell
-673
Closed -$217K 153
2024
Q3
$217K Sell
673
-7
-1% -$2.29K 0.12% 143
2024
Q2
$212K Sell
680
-31
-4% -$9.11K 0.13% 138
2024
Q1
$202K Buy
711
+4
+0.6% +$1.17K 0.13% 132
2023
Q4
$204K Buy
+707
New +$193K 0.15% 124

Other funds holding AMGN

Lakeridge Wealth Management's AMGN Position: Q2 2026 in Review

Lakeridge Wealth Management increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $4.79K and bringing the position to 642 shares worth $232K. The position accounts for 0.09% of the portfolio, ranked #167.

Lakeridge Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 6 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lakeridge Wealth Management held 642 shares of Amgen worth $232K as of Q2 2026.
  • Lakeridge Wealth Management bought 14 Amgen shares in Q2 2026, an estimated $4.79K.
  • Amgen made up 0.09% of Lakeridge Wealth Management's portfolio in Q2 2026, its #167 holding.
  • Lakeridge Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 6 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lakeridge Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.